Skip to content 
Generate Biomedicines, Inc. is a clinical-stage generative biology company focusing on the Artificial intelligence (AI) revolution in biotechnology and drug design and development. The Company is engaged in the field of generative biology using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its Generate Platform integrates generative and predictive models that learn design principles from proprietary data and graph neural networks, among other architectures. Its lead product candidate, GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma. Its other product candidates include GB-4362, a systemically administered monoclonal antibody designed to neutralize free monomethyl auristatin E (MMAE) as an adjunctive therapy to antibody-drug conjugate (ADC) molecules with an MMAE payload, as well as GB-5267, an armored, MUC16-directed CAR-T cell therapy candidate. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| GENB | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| GENB | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 39.17 |
| P/B | 0.00 |
| EV/R | 44.00 |
| EV/Ebitda | NM |
Generate Biomedicines (GENB) share price today is $13.055
Yes, Indians can buy shares of Generate Biomedicines (GENB) on Vested. To buy
Yes, you can purchase fractional shares of Generate Biomedicines (GENB) via the Vested app. You can start investing in Generate Biomedicines (GENB) with a minimum investment of $1.
You can invest in shares of Generate Biomedicines (GENB) via Vested in three simple steps:
The 52-week high price of Generate Biomedicines (GENB) is $16. The 52-week low price of Generate Biomedicines (GENB) is $11.
The price-to-earnings (P/E) ratio of Generate Biomedicines (GENB) is
The price-to-book (P/B) ratio of Generate Biomedicines (GENB) is 0.00
The dividend yield of Generate Biomedicines (GENB) is 0.00%
The market capitalization of Generate Biomedicines (GENB) is $1.62B
The stock symbol (or ticker) of Generate Biomedicines is GENB
Consider the share price of Generate Biomedicines as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Generate Biomedicines has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Generate Biomedicines shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Generate Biomedicines stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Generate Biomedicines and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Generate Biomedicines stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
